Comoros vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Comoros
100.0%
in 2023
Israel
100.0%
in 2024
Comoros rank
1st
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Comoros
- Israel
How they compare
Comoros currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2018 it was Israel ahead.
Comoros ranks 1st and Israel ranks 1st of 144 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Comoros | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 91.8% | 97.8% | 6.0% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Comoros or Israel?
- Comoros, at 100.0% against 100.0% in Israel as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Comoros and Israel?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and Israel?
- 6 years are reported by both, from 2018 to 2023.
- How do Comoros and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Comoros ranks 1st and Israel ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.